Quick Take The Series D fundraising saw participation from existing and new investors including Fearless Ventures, Falcon Edge Capital, Pura Vida Pro LLC, Catalio Capital Management, Michael Auerbach’s Subversive Capital, Highline Capital, and Woodline Partners Proceeds from this financing round will support the expansion and development of the atai’s drug candidate pipeline, enabling technologies, and…